BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37039832)

  • 21. Role of consolidative thoracic radiation in extensive-stage small-cell lung cancer with first-line chemoimmunotherapy: a retrospective study from a single cancer center.
    Li Y; Jing W; Jing X; Sun Y; Tang X; Guo J; Zhang Y; Zhu H
    Discov Oncol; 2023 May; 14(1):55. PubMed ID: 37142872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thoracic Radiotherapy in Extensive Disease Small Cell Lung Cancer: Multicenter Prospective Observational TRENDS Study.
    Cozzi S; Bruni A; Ruggieri MP; Borghetti P; Scotti V; Franceschini D; Fiore M; Taraborrelli M; Salvi F; Galaverni M; Savoldi L; Braglia L; Botti A; Finocchi Ghersi S; Niccolò GL; Lohr F; Iotti C; Ciammella P
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of PD-1/PD-L1 inhibitor plus chemotherapy versus chemotherapy alone as first-line treatment for extensive-stage small cell lung cancer: A systematic review and meta-analysis.
    Zhang S; Li S; Cheng Y
    Thorac Cancer; 2020 Dec; 11(12):3536-3546. PubMed ID: 33058504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of durvalumab + chemotherapy
    Zou Y; Ren X; Zhang H; Wang Y; Wang H; Bai R; Zhang Z; Sun G; Xu L
    J Thorac Dis; 2023 Jun; 15(6):3339-3349. PubMed ID: 37426159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune-checkpoint inhibitors plus chemotherapy versus chemotherapy as first-line treatment for patients with extensive-stage small cell lung cancer.
    Zhou F; Zhao W; Gong X; Ren S; Su C; Jiang T; Zhou C
    J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32900864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of first-line anti-PD-L1 blockades combined with brain radiotherapy for extensive-stage small-cell lung cancer with brain metastasis.
    Ma J; Tian Y; Hao S; Zheng L; Hu W; Zhai X; Meng D; Zhu H
    J Neurooncol; 2022 Sep; 159(3):685-693. PubMed ID: 35976547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiation therapy for extensive-stage small-cell lung cancer in the era of immunotherapy.
    Tian Y; Ma J; Jing X; Zhai X; Li Y; Guo Z; Yu J; Zhu H
    Cancer Lett; 2022 Aug; 541():215719. PubMed ID: 35597478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Consolidative Thoracic Radiation Therapy After First-Line Chemotherapy and Immunotherapy in Extensive-Stage Small Cell Lung Cancer: A Multi-Institutional Case Series.
    Diamond BH; Verma N; Shukla UC; Park HS; Koffer PP
    Adv Radiat Oncol; 2022; 7(2):100883. PubMed ID: 35387416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy of thoracic radiotherapy in extensive stage small cell lung cancer with baseline brain metastases: a multi-institutional retrospective cohort study.
    Zheng Z; Yuan X; Zhou Y; Chu L; Yang X; Ni J; Chu Q; Chu X; Liu Y; Zhu Z
    Ann Transl Med; 2023 Jan; 11(2):60. PubMed ID: 36819545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [First-line chemotherapy and its survival analysis of 394 patients with extensive-stage small cell lung cancer in a single institute].
    Ma M; Wang M; Xu Y; Hu K; Liu H; Li L; Zhong W; Zhang L; Zhao J; Wang H
    Zhongguo Fei Ai Za Zhi; 2014 Jan; 17(1):8-14. PubMed ID: 24398308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can consolidative thoracic radiotherapy improve outcomes in extensive-disease small cell lung cancer after chemotherapy with complete/near-complete responders?
    Kirakli EK; Yilmaz H; Akcay C; Komurcuoglu B; Yilmaz U
    J Cancer Res Ther; 2020; 16(4):752-756. PubMed ID: 32930114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What is the role of radiotherapy for extensive-stage small cell lung cancer in the immunotherapy era?
    Nesbit EG; Leal TA; Kruser TJ
    Transl Lung Cancer Res; 2019 Sep; 8(Suppl 2):S153-S162. PubMed ID: 31673520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of First-Line Treatments for Patients With Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-analysis.
    Zhou T; Zhang Z; Luo F; Zhao Y; Hou X; Liu T; Wang K; Zhao H; Huang Y; Zhang L
    JAMA Netw Open; 2020 Oct; 3(10):e2015748. PubMed ID: 33074323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic Therapy of Extensive Stage Small Cell Lung Cancer in the Era of Immunotherapy.
    Ragavan M; Das M
    Curr Treat Options Oncol; 2020 Jun; 21(8):64. PubMed ID: 32601742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcomes of extensive-stage small cell lung cancer patients treated with thoracic radiotherapy at different times and fractionations.
    Han J; Fu C; Li B
    Radiat Oncol; 2021 Mar; 16(1):47. PubMed ID: 33663551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose escalation and associated predictors of survival with consolidative thoracic radiotherapy in extensive stage small cell lung cancer (SCLC): A National Cancer Database (NCDB) propensity-matched analysis.
    Hasan S; Renz P; Turrisi A; Colonias A; Finley G; Wegner RE
    Lung Cancer; 2018 Oct; 124():283-290. PubMed ID: 30268474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of thoracic radiotherapy combined with chemo-immunotherapy in patients with extensive-stage small cell lung cancer: a multicenter retrospective analysis.
    Cai Z; Gu X; Xie J; Cheng D; Chen J; Cheng J; Ye J; Lv T
    Transl Lung Cancer Res; 2023 Oct; 12(10):1987-2000. PubMed ID: 38025813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy versus standard chemotherapy for treatment of extensive-stage small-cell lung cancer: a systematic review.
    Liu X; Xing H; Zhang H; Liu H; Chen J
    Immunotherapy; 2021 Aug; 13(12):989-1000. PubMed ID: 34114477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protocol of the TREASURE study: Thoracic RadiothErapy with Atezolizumab in Small cell lUng canceR Extensive disease - a randomized, open-label, multicenter phase II trial.
    Bozorgmehr F; Christopoulos P; Chung I; Cvetkovic J; Feißt M; Krisam J; Schneider MA; Heußel CP; Kreuter M; Müller DW; Thomas M; Rieken S
    BMC Cancer; 2022 Sep; 22(1):1011. PubMed ID: 36153496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combining PD-1 or PD-L1 inhibitors with chemotherapy is a good strategy for the treatment of extensive small cell lung cancer: A retrospective analysis of clinical studies.
    Luo H; Song G; Wang D; Li M; Dai N
    Front Immunol; 2022; 13():1059557. PubMed ID: 36544769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.